Schapira AH, Olanow CW. (2003). Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease. Annals of neurology. 53 Suppl 3 [PubMed]

See more from authors: Schapira AH · Olanow CW

References and models cited by this paper
References and models that cite this paper

Muddapu VR, Mandali A, Chakravarthy VS, Ramaswamy S. (2019). A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity. Frontiers in neural circuits. 13 [PubMed]

This website requires cookies and limited processing of your personal data in order to function. By continuing to browse or otherwise use this site, you are agreeing to this use. See our Privacy policy and how to cite and terms of use.